The research, by Innovative Medicines Initiative (IMI) project IDEA-FAST, involved people with neurodegenerative and inflammatory diseases, where fatigue can have a major impact on patients’ quality of life.

Innovative Medicines Initiative project UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with TB.

IMI project SOPHIA is shedding new light on the mechanisms that can cause type 2 diabetes in obesity, as well as the factors that keep some people with obesity diabetes-free.

An Innovative Medicines Initiative project is studying how simple blood tests or scans could replace surgical biopsies as a means to identify people with the liver disease non-alcoholic staetohepatitis (NASH).

New recommendations from Innovative Medicines Initiative project PREFER detail when and how best to incorporate patient preferences into drug development processes.

IMI project RESCEU is shedding new light on the burden of respiratory syncytial virus, a common infectious disease that can cause serious illness in young children and other vulnerable groups.

The Innovative Medicines Initiative project ConcePTION is exploring how a learning healthcare system approach could advance medicines safety during pregnancy and breastfeeding.

Age-related macular degeneration (AMD) is a leading cause of blindness. The EMA has issued a Letter of Support to Innovative Medicines Initiative project MACUSTAR for its work on new measures to assess AMD in clinical trials.

IMI-funded researchers found that COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.

Scientists from Innovative Medicines Initiative projects iPiE and PREMIER used a tool called ePiE to predict levels of ibuprofen in four major European river basins.